Literature DB >> 26629074

The protective effect of tadalafil on IMA (ischemia modified albumin) levels in experimental renal ischemia-reperfusion injury.

Akin Soner Amasyali1, Abdullah Akkurt1, Ercan Kazan1, Mustafa Yilmaz2, Bulent Erol3, Yuksel Yildiz4, Haluk Erol1.   

Abstract

INTRODUCTION: To investigate the effect of the tadalafil in experimental renal I/R injury and to evaluate these changes with IMA (nonspesific early biomarker of ischemia), NO and MDA levels.
MATERIALS AND METHODS: Twenty four female Wistar rats were randomly divided into 3 groups (n=8): Group I, sham; Group II, 60 min I/R; Group III, 60 min I/R plus tadalafil. Tadalafil was administered via an orogastric tube (10 mg/kg) 24 h prior to the procedure. After ischemia of the left kidney and 1 h of reperfusion, blood samples were obtained, and the kidney was removed.
RESULTS: Statistically significant histopathologic changes were exist between groups, with the most severe injury was determined in group II in comparison to the others (X(2)=21,803, P=0.000). Also mean serum IMA levels were higher in group II, but not statistically significant (19.83±7.81 U/ml, 22.26±7.14 U/ml and 19.82±7.77 U/ml, P=0.613). In addition, NO values were lower in I/R groups (P=0.049). There were no differences among the groups in terms of MDA.
CONCLUSIONS: IMA may be used as a nonselective biomarker for IR injury before the occurrence of necrosis. Decreased IMA levels may indicate the nephroprotective effect of tadalafil in renal IR injury.

Entities:  

Keywords:  Tadalafil; ischemia modified albumin; renal ischemia reperfusion injury

Year:  2015        PMID: 26629074      PMCID: PMC4658963     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  31 in total

1.  Investigation of the possibility of using ischemia-modified albumin in testicular torsion: an experimental study.

Authors:  Omer Kutlu; Ahmet Mentese; Suha Turkmen; Suleyman Turedi; Abdulkadir Gunduz; Esin Yulug; Ahmet Alver; Suleyman Caner Karahan
Journal:  Fertil Steril       Date:  2010-05-08       Impact factor: 7.329

2.  Semiautomated measurement of nitrate in biological fluids.

Authors:  J A Navarro-Gonzálvez; C García-Benayas; J Arenas
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

3.  Tadalafil for prevention of renal dysfunction secondary to renal ischemia.

Authors:  Stephen Faddegon; Sara L Best; Ephrem O Olweny; Yung K Tan; Samuel K Park; Saad A Mir; Jeffrey A Cadeddu
Journal:  Can J Urol       Date:  2012-06       Impact factor: 1.344

4.  Sildenafil attenuates renal ischemia reperfusion injury by decreasing leukocyte infiltration.

Authors:  Ozgur Oruc; Kubilay Inci; Fazil Tuncay Aki; Dilara Zeybek; Sevda F Muftuoglu; Kamer Kilinc; Ali Ergen
Journal:  Acta Histochem       Date:  2009-03-25       Impact factor: 2.479

5.  Alteration of ischemia modified albumin and nitric oxide levels in hypothyroidism.

Authors:  Kiran Dahiya; Monica Verma; Rakesh Dhankhar; Veena Singh; Pratap S Ghalaut; Shashi Seth
Journal:  Clin Lab       Date:  2014       Impact factor: 1.138

6.  Effect of deep vein thrombosis on ischaemia-modified albumin levels.

Authors:  A Mentese; U Mentese; S Turedi; A Gunduz; S C Karahan; M Topbas; A Turan; T Patan; S Turkmen; G Okur; M S Eminagaoglu
Journal:  Emerg Med J       Date:  2008-12       Impact factor: 2.740

7.  Tadalafil improves short-term memory by suppressing ischemia-induced apoptosis of hippocampal neuronal cells in gerbils.

Authors:  Il-Gyu Ko; Mal-Soon Shin; Bo-Kyun Kim; Sung-Eun Kim; Yun-Hee Sung; Tae-Soo Kim; Min-Chul Shin; Han-Jin Cho; Sin-Chul Kim; Sang-Hoon Kim; Khae-Hawn Kim; Dong-Hoon Shin; Chang-Ju Kim
Journal:  Pharmacol Biochem Behav       Date:  2008-10-29       Impact factor: 3.533

8.  Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits.

Authors:  Ramzi Ockaili; Fadi Salloum; John Hawkins; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09       Impact factor: 4.733

9.  Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease.

Authors:  Jürgen Falkensammer; Andreas Frech; Nikolaus Duschek; Simon Gasteiger; Tatjana Stojakovic; Hubert Scharnagl; Kurt Huber; Gustav Fraedrich; Andreas Greiner
Journal:  Clin Chim Acta       Date:  2014-09-03       Impact factor: 3.786

10.  Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.

Authors:  Akin Soner Amasyali; Canan Kucukgergin; Selcuk Erdem; Oner Sanli; Sule Seckin; Ismet Nane
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

View more
  2 in total

Review 1.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

2.  Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers.

Authors:  Sally A El Awdan; Rehab F Abdel Rahman; Heba M Ibrahim; Rehab R Hegazy; Salma A El Marasy; Manal Badawi; Mahmoud S Arbid
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.